In vitro immunomodulatory effect of Bifidobacterium bifidum and Lactobacillus reuteri cell free extracts

Keywords: probiotic derivatives; peritoneal macrophages; peripheral blood mononuclear cells; innate immunity; cytokines.


Recent studies have shown that alterations of the immune response in the gastrointestinal mucosa are key components of the mechanism of the probiotic action of beneficial bacteria. Most of the beneficial effects of probiotics are due to the action of their structural components and metabolites. Macrophages are first-line defense cells of the immune system, which not only participate in the detection, phagocytosis and destruction of harmful microorganisms, but also determine the nature of the subsequent immune response by presenting antigens to T-cells and initiating inflammation by releasing cytokines. We researched the effect of two types of cell-free extracts (CFEs) containing probiotic derivatives (structural components and metabolites of bacteria) Bifidobacterium bifidum 1 (BbCFE) and Lactobacillus reuteri DSM 17938 (LrCFE) on the activity of mouse peritoneal macrophages and on the ability of peripheral human blood mononuclear cells to produce cytokines. CFEs were obtained by culturing probiotics in their own disintegrates and then removing cells and cell debris by centrifugation and filtration. Peritoneal macrophages were isolated from mice. Some of them were infected in vitro by Salmonella thyphimurium. Uninfected and infected macrophages were incubated in culture medium containing (30% vol) or not containing CFEs at 37 °С in a microaerobic atmosphere (5% СО2) for 18 hours. After incubation, peritoneal macrophages were lysed. The obtained suspensions were centrifuged and supernatants were carefully collected. Macrophages activity was assessed by the nitrites level, superoxide dismutase (SOD), lactate dehydrogenase (LDH) activity and antiinflammatory cytokines levels in supernatants using spectrophotometric method. Peripheral mononuclear cells were isolated from the blood of healthy volunteers. The ability of peripheral mononuclear blood cells to produce antiinflammatory cytokines was evaluated after cell stimulation with lipopolysaccharide (LPS) and incubation with or without CFEs. Cytokine levels in supernatants were determined using enzyme-linked immunosorbent assay (ELISA). After infection with S. thyphimurium in macrophages, nitrite levels increased 5.5-fold, SOD activity 4.8-fold, and LDH 2-fold. Both studied CFEs exerted a similar effect on the macrophages’ activity. Addition of BbCFE to the incubation medium of infected macrophages resulted in a 4-fold decrease in nitrite levels, and the addition of LrCFE was accompanied by a decrease in nitrite levels to levels in intact cells. Under the influence of both CFEs, the activity of SOD and LDH was significantly reduced and did not differ significantly from the activity of these enzymes in intact cells. BbCFE and LrCFE did not have a significant effect on nitrite levels, SOD and LDH activity in intact macrophages. Under the influence of BbCFE, there was a 2-fold decrease in the production of TNF, a 2-fold increase in IL10 production, and a 30% increase in IL6 production by mononuclear cells. LrCFE caused a decrease in TNF production by 26.7% and IL6 by 36%, and IL10 by 1.9 times. Thus, the studied CFEs normalized the nitrite levels in peritoneal macrophages infected with S. thyphymurium and infection-induced activation of SOD and LDH enzymes. This demonstrates their ability to modulate oxidative processes in macrophages. In addition, under the influence of the investigated CFEs, there was a decrease in the production of pro-inflammatory cytokines (TNFα and IL-6) and increased production of anti-inflammatory cytokine (IL-10) by human peripheral mononuclear cells. The results of the study indicate the ability of CFEs by influencing the functions of innate immunity cells to restrict the inflammatory response and oxidative stress. Based on this, CFEs can be considered as promising agents for the treatment of inflammatory diseases.


Azad, M. A. K., Sarker, M., & Wan, D. (2018). Immunomodulatory effects of probiotics on cytokine profiles. BioMed Research International, 2018, 1–10.

Bergmeyer, H. U., & Bernt, E. (1974). UV-assay with pyruvate and NADH. In: Methods of enzymatic analysis. Academic Press. Pp. 574–579.

Blacher, E., Levy, M., Tatirovsky, E., & Elinav, E. (2017). Microbiome-modulated metabolites at the interface of host immunity. The Journal of Immunology, 198(2), 572–580.

Bresciani, G., da Cruz, I. B. M., & González-Gallego, J. (2015). Manganese super­oxide dismutase and oxidative stress modulation. Advances in Clinical Chemistry, 68, 87–130.

Britton, R. A. (2017). Lactobacillus reuteri. In: Floch, M., Ringel, Y., & Walker, W. (Eds.). The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. Academic Press, London. Pp. 89–97.

Cervantes-Barragan, L., Chai, J. N., Tianero, M. D., Di Luccia, B., Ahern, P. P., Mer­riman, J., Cortez, V. S., Caparon, M. G., Donia, M. S., Gilfillan, S., Cella, M., Gordon, J. I., Hsieh, C. S., & Colonna, M. (2017). Lactobacillus reuteri induces gut intraepithelial CD4+CD8αα+T cells. Science, 357(6353), 806–810.

De Gregorio, P. R., Juárez Tomás, M. S., & Nader-Macías, M. E. F. (2015). Immunomodulation of Lactobacillus reuteri CRL1324 on Group B Streptococcus vaginal colonization in a murine experimental model. American Journal of Reproductive Immunology, 75(1), 23–35.

Gao, C., Major, A., Rendon, D., Lugo, M., Jackson, V., Shi, Z., Mori-Akiyama, Y., & Versalovic, J. (2015). Histamine H2 receptor-mediated suppression of intestinal inflammation by probiotic Lactobacillus reuteri. mBio, 6(6), e01358-15.

Garbi, N., Arnold, B., Gordon, S., Hämmerling, G. J., & Ganss, R. (2004). CpG mo­tifs as proinflammatory factors render autochthonous tumors permissive for infiltration and destruction. The Journal of Immunology, 172(10), 5861–5869.

González-Rodríguez, I., Ruiz, L., Gueimonde, M., Margolles, A., & Sánchez, B. (2012). Factors involved in the colonization and survival of bifidobacteria in the gastrointestinal tract. FEMS Microbiology Letters, 340(1), 1–10.

Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Analytical Biochemistry, 126(1), 131–138.

Grievink, H. W., Luisman, T., Kluft, C., Moerland, M., & Malone, K. E. (2016). Comparison of three isolation techniques for human peripheral blood mononuclear cells: Cell recovery and viability, population composition, and cell functionality. Biopreservation and Biobanking, 14(5), 410–415.

Hemarajata, P., Gao, C., Pflughoeft, K. J., Thomas, C. M., Saulnier, D. M., Spinler, J. K., & Versalovic, J. (2013). Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri. Journal of Bacteriology, 195(24), 5567–5576.

Hoang, T. K., Freeborn, J., Wang, T., Mai, T., He, B., Park, S., Tran, D. Q., Roos, S., Rhoads, J. M., & Liu, Y. (2019). Human breast milk promotes the immunomodulatory function of probiotic Lactobacillus reuteri DSM 17938 in the neonatal rat intestine. Journal of Probiotics and Health, 7(1), 210.

Knysh, O. V., Isaenko, O. Y., Babych, E. M., Kompaniets, A. M., Pakhomov, O. V., Polyanska, V. P., Zachepylo, S. V., & Danilova, I. S. (2018). Antimicrobial activity of bifidobacteria derivatives after storage in a frozen state. Problems of Cryobiology and Cryomedicine, 28(3), 237–248.

Kono, Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics, 186(1), 189–195.

Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016). Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: A systematic review of randomized controlled trials. Genome Medicine, 8(1), 52.

Kysera, Y. V., Storchak, Y. G., & Gutyj, B. V. (2018). Experimental study of immunoprophylactic anti-pneumococcal medicine and its immunogenic properties. Ukrainian Journal of Ecology, 8(1), 307–316.

Lee, J., Yang, W., Hostetler, A., Schultz, N., Suckow, M. A., Stewart, K. L., Kim, D. D., & Kim, H. S. (2016). Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice. BMC Microbiology, 16, 1.

Levy, M., Blacher, E., & Elinav, E. (2017). Microbiome, metabolites and host immunity. Current Opinion in Microbiology, 35, 8–15.

Levy, M., Thaiss, C. A., & Elinav, E. (2016). Metabolites: Messengers between the microbiota and the immune system. Genes and Development, 30(14), 1589–1597.

Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.

Meltzer, M. S., Stevenson, M. M., Tucker, R. W., & Leonard, E. J. (1976). Peritoneal macrophages from BCG-infected mice: Tumor cytotoxicity and chemotactic responses in vitro. In: The macrophage in neoplasia. Academic Press, New York. P. 211.

Mu, Q., Tavella, V. J., & Luo, X. M. (2018). Role of Lactobacillus reuteri in human health and diseases. Frontiers in Microbiology, 9, 757.

O’Callaghan, A., & van Sinderen, D. (2016). Bifidobacteria and their role as members of the human gut microbiota. Frontiers in Microbiology, 7, 925.

O’Neill, I., Schofield, Z., & Hall, L. J. (2017). Exploring the role of the microbiota member Bifidobacterium in modulating immune-linked diseases. Emerging Topics in Life Sciences, 1(4), 333–349.

Patel, R., & DuPont, H. L. (2015). New approaches for bacteriotherapy: Prebio­tics, new-generation probiotics, and synbiotics. Clinical Infectious Diseases, 60(suppl. 2), S108–S121.

Quigley, E. M. M. (2016). Bifidobacterium bifidum. In: Floch, M. H., Ringel, Y., & Walker, W. A. (Eds.). The microbiota in gastrointestinal pathophysiology: Implications for human health, prebiotics, probiotics, and dysbiosis. Elsevier. Part B, Chaptter 14, 131–133.

Qureshi, T., Templeton, J. W., & Adams, L. G. (1996). Intracellular survival of Bru­cella abortus, Mycobacterium bovis BCG, Salmonella dublin, and Salmonella typhimurium in macrophages from cattle genetically resistant to Brucella abortus. Veterinary Immunology and Immunopathology, 50(1–2), 55–65.

Sarkar, A., & Mandal, S. (2016). Bifidobacteria – Insight into clinical outcomes and mechanisms of its probiotic action. Microbiological Research, 192, 159–171.

Singh, A., Vishwakarma, V., & Singhal, B. (2018). Metabiotics: The functional metabolic signatures of probiotics: Current state-of-art and future research priorities. Metabiotics: Probiotics effector molecules. Advances in Bioscience and Biotechnology, 9(4), 147–189.

Soufli, I., Toumi, R., Rafa, H., & Touil-Boukoffa, C. (2016). Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World Journal of Gastrointestinal Pharmacology and Therapeutics, 7(3), 353.

Taha-Abdelaziz, K., Astill, J., Kulkarni, R. R., Read, L. R., Najarian, A., Farber, J. M., & Sharif, S. (2019). In vitro assessment of immunomodulatory and anti-Campylobacter activities of probiotic lactobacilli. Scientific Reports, 9, 17903.

Verma, R., Lee, C., Jeun, E.-J., Yi, J., Kim, K. S., Ghosh, A., Byun, S., Lee, C.-G., Kang, H.-J., Kim, G.-C., Jun, C.-D., Jan, G., Suh, C.-H., Jung, J.-Y., Sprent, J., Rudra, D., De Castro, C., Molinaro, A., Surh, C. D., & Im, S.-H. (2018). Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells. Science Immunology, 3(28), eaat6975.

Wang, P., Li, Y., Xiao, H., Shi, Y., Le, G. W., & Sun, J. (2016). Isolation of Lactobacillus reuteri from Peyer’s patches and their effects on sIgA production and gut microbiota diversity. Molecular Nutrition and Food Research, 60(9), 2020–2030.

Wasilewski, A., Zielińska, M., Storr, M., & Fichna, J. (2015). Beneficial effects of probiotics, prebiotics, synbiotics, and psychobiotics in inflammatory Bowel disease. Inflammatory Bowel Diseases, 21(7), 1674–1682.

Yu, H.-S., Lee, N.-K., Choi, A.-J., Choe, J.-S., Bae, C. H., & Paik, H.-D. (2019). Anti-inflammatory potential of probiotic strain Weissella cibaria JW15 isolated from kimchi through regulation of NF-κB and MAPKs pathways in LPS-induced RAW 264.7 cells. Journal of Microbiology and Biotechnology, 29(7), 1022–1032.

Zhang, M., Sun, K., Wu, Y., Yang, Y., Tso, P., & Wu, Z. (2017). Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Frontiers in Immunology, 8, 942.

Zitvogel, L., Daillère, R., Roberti, M. P., Routy, B., & Kroemer, G. (2017). Anticancer effects of the microbiome and its products. Nature Reviews Micro­biology, 15(8), 465–478.

Zmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., Federici, S., Horn, M., Cohen, Y., Moor, A. E., Zeevi, D., Korem, T., Kotler, E., Harmelin, A., Itzkovitz, S., Maharshak, N., Shibolet, O., Pevsner-Fischer, M., Shapiro, H., Sharon, I., Halpern, Z., Segal, E., & Elinav, E. (2018). Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell, 174(6), 1388–1405.

How to Cite
Knysh, O. V., Pogorila, M. S., & Voyda, Y. V. (2020). In vitro immunomodulatory effect of Bifidobacterium bifidum and Lactobacillus reuteri cell free extracts . Regulatory Mechanisms in Biosystems, 11(1), 93-97.